Arthritis - Disease Profiles and Comparison

Specific Arthritic Conditions Introduction Arthritis is inflammation of joints that can result from mechanical wear, autoimmune attacks, crystal deposition, or infection. While there are over 100 types of arthritis, a few specific conditions account for the majority of cases and appear frequently in clinical practice and on exams. This section covers the most important arthritic conditions: how they develop, how they present clinically, how they're diagnosed, and how they're treated. Understanding the key differences between these conditions—particularly osteoarthritis versus rheumatoid arthritis—is essential because they require completely different management approaches. Osteoarthritis: The Most Common Arthritis Osteoarthritis (OA) is the most prevalent form of arthritis and results from mechanical wear and tear of joint cartilage over time. Rather than an autoimmune condition, OA is essentially degenerative—the protective cartilage covering bones gradually deteriorates. Who gets osteoarthritis? Age is the strongest predictor. Over 30% of women have radiographic evidence of OA by age 65. Any joint can be affected, but weight-bearing joints (knees, hips) and frequently-used small joints (fingers, toes) are most commonly involved. Diagnosis: X-ray Findings X-ray is the primary diagnostic tool and typically shows four characteristic findings: Joint space narrowing (cartilage has worn away, so the space between bones decreases) Osteophytes (bone spurs that form at joint margins) Sclerosis (abnormal bone hardening) Subchondral cysts (small cavities in bone beneath the remaining cartilage) The absence of systemic inflammatory signs (fever, systemic swelling) helps distinguish OA from other arthritides. Rheumatoid Arthritis: An Autoimmune Condition Rheumatoid arthritis (RA) is fundamentally different from OA—it's an autoimmune disorder where the body's immune system attacks the joint's synovium (lining) and articular cartilage. This leads to inflammation, joint destruction, and can cause severe deformity if untreated. Key Clinical Features RA typically causes symmetric joint involvement—if the right knee is affected, the left knee usually is too. The small joints of the hands are most commonly affected (fingers and wrists), though knees and elbows frequently develop disease. RA commonly affects young to middle-aged adults (age 20+), though it can occur at any age. Why Does RA Cause More Damage? RA damages joints through two main mechanisms: Pro-inflammatory cytokines (especially TNF-α and IL-17) drive persistent inflammation in the synovium RANKL pathway activates osteoclasts—bone-resorbing cells—causing erosions (bone loss) This is critical: RA doesn't just wear away cartilage like OA; it actively erodes bone. This is why early, aggressive treatment is essential—prolonged disease activity leads to irreversible bone damage and joint deformity. Clinical Deformities in Advanced RA When RA progresses without treatment, distinctive hand deformities develop: Swan-neck deformity: hyperextension of the middle finger joint with flexion of the end joint Boutonnière deformity: flexion of the middle joint with hyperextension of the end joint Ulnar deviation: fingers drift toward the pinky side of the hand These deformities reflect the combined effects of cartilage loss, bone erosion, and tendon damage. Role of Conventional DMARDs Disease-modifying antirheumatic drugs (DMARDs) not only slow disease progression—they can actually allow partial repair of bone erosions. This is remarkable because it means bone damage isn't always permanent if treated aggressively early. Osteoarthritis vs. Rheumatoid Arthritis: Critical Distinctions This comparison is essential because the two conditions require opposite treatment strategies. OA is managed with analgesics and joint protection, while RA demands immunosuppression. Radiographic Findings | Feature | Osteoarthritis | Rheumatoid Arthritis | |---------|---|---| | Joint space | Narrowed | Narrowed | | Bone spurs | Present (osteophytes) | Absent | | Bone erosions | Absent | Present ("punched-out" lesions) | | Sclerosis | Present | Absent | | Pattern | Asymmetric (variable) | Symmetric | Clinical Presentation OA: Local pain, no systemic symptoms, affects large and small joints variably RA: Symmetric joint swelling, systemic inflammation (fever possible), morning stiffness, characteristic hand deformities if untreated The key discriminator: RA causes symmetric joint involvement with bone erosions; OA causes asymmetric wear with bone spurs but no erosions. Gout and Crystal-Induced Arthritides Gout represents a different mechanism entirely—crystal deposition in joints causes acute inflammation. What Causes Gout? Gout develops when uric acid crystals precipitate in joints. This typically occurs in people with hyperuricemia (elevated uric acid levels), often triggered by: Excessive alcohol consumption (especially beer) High-purine diet (red meat, organ meats) Genetic predisposition Certain medications (diuretics) Clinical Presentation Gout characteristically strikes suddenly, often affecting a single joint—most commonly the big toe, though it can involve knees, fingers, and other joints. The affected joint becomes: Swollen Warm to touch Red Extremely painful (patients often cannot bear weight) Attacks are self-limited (lasting days to weeks) even without treatment, but recur if the underlying hyperuricemia isn't addressed. Acute Flare Management Three medication classes treat acute gout attacks: NSAIDs (like indomethacin)—reduce inflammation Colchicine—inhibits neutrophil migration into joints, reducing inflammation Glucocorticoids—suppress inflammation systemically Long-Term Management: Urate-Lowering Therapy The goal is to prevent future attacks by lowering serum uric acid levels. Two strategies exist: Uric acid synthesis inhibitors Allopurinol (first-line) Febuxostat Uricosuric drugs (increase urinary urate excretion) Probenecid Important note: Don't start urate-lowering therapy during an acute attack—this can paradoxically worsen symptoms. Begin after the flare resolves. Pseudogout: Crystal Arthritis Without Uric Acid Pseudogout results from calcium pyrophosphate crystal deposition (CPPD disease) rather than uric acid. It mimics gout clinically but is caused by different crystals. Key Difference from True Gout There are no disease-modifying treatments that prevent CPPD crystal formation. Management focuses purely on symptomatic relief during acute flares: NSAIDs Colchicine Corticosteroid injections Joint aspiration (removes inflammatory fluid) <extrainfo> Unlike gout, which can be prevented with urate-lowering therapy, pseudogout management is entirely acute-focused because we can't prevent calcium pyrophosphate deposition. </extrainfo> Systemic Lupus Erythematosus (SLE) Arthritis Systemic lupus erythematosus is an autoimmune condition affecting multiple organ systems. Arthritis is extremely common—up to 90% of SLE patients develop musculoskeletal involvement. SLE arthritis is typically non-erosive (doesn't permanently damage bone like RA does) but causes significant pain and swelling. Management follows the broader SLE treatment approach, which may include antimalarial drugs (hydroxychloroquine), NSAIDs for mild disease, and immunosuppressive agents for severe involvement. <extrainfo> Advanced imaging (ultrasound, MRI) can detect subclinical synovitis in SLE, helping guide treatment escalation before symptoms worsen. </extrainfo> Infectious (Septic) Arthritis: A Medical Emergency Septic arthritis occurs when bacteria spread via the bloodstream and seed into a joint space. This is a medical emergency requiring rapid diagnosis and treatment. Clinical Presentation The onset is acute with: Sudden joint pain and swelling Chills and fever Inability to move the joint Why Is It Urgent? Bacteria rapidly destroy articular cartilage. Irreversible joint damage can occur within days without treatment. Early antibiotic therapy (after blood and joint fluid cultures) is essential. Viral Arthritis: A Different Story Viral causes account for only 1% of septic arthritis cases. Notably, SARS-CoV-2 typically causes reactive arthritis (the immune system reacts to viral antigens) rather than true septic arthritis (bacteria growing in the joint). This distinction matters for treatment—reactive arthritis doesn't require antibiotics. Psoriatic Arthritis Psoriatic arthritis is an autoimmune condition often associated with psoriasis (a skin disease causing scaly patches and itching). The arthritis usually follows skin symptoms, though joint symptoms can occasionally precede or occur without skin involvement. Clinical Features Continuous joint pain, stiffness, and swelling Can cause severe destruction of hand joints if untreated More likely to affect the DIP joints (the knuckle closest to the fingertip)—unlike RA, which spares DIP joints Treatment Current therapy uses immunosuppressive medications to reduce autoimmune attacks, similar to RA management. NSAIDs address pain and inflammation, but disease-modifying agents are often necessary to prevent joint damage. Key Pathophysiologic Mechanisms in RA Understanding why RA damages joints differently than OA helps explain treatment strategies. IL-17 and Synovial Destruction Interleukin-17 (IL-17), a pro-inflammatory cytokine, promotes matrix metalloproteinase (MMP) production in the synovium. MMPs are enzymes that break down collagen—the structural protein in cartilage. IL-17 works synergistically with TNF-α to amplify this cartilage-destroying process. RANKL and Bone Erosion The RANKL pathway is crucial for bone damage in RA. RANKL (a cytokine produced by inflamed synovial cells) activates osteoclasts—bone-resorbing cells. This explains why RA causes bone erosions rather than just cartilage wear: the inflammatory environment actively stimulates bone resorption. Clinical Implication: Blocking IL-17 or RANKL pathways reduces bone loss. This is why targeted biologic therapies that inhibit these pathways have become important RA treatments. Summary Table: Distinguishing Features at a Glance | Condition | Mechanism | Key Joints | Pattern | Deformity | Bone Erosions | |-----------|-----------|-----------|---------|-----------|---------------| | OA | Mechanical wear | Knees, hips, fingers | Asymmetric | None typical | No | | RA | Autoimmune | Fingers, wrists, knees | Symmetric | Swan-neck, Boutonnière | Yes | | Gout | Uric acid crystals | Big toe first, then spreads | Variable | Usually none acutely | Possible (chronic) | | SLE arthritis | Autoimmune | Hands, wrists | Variable | None (non-erosive) | No | | Psoriatic | Autoimmune | DIP joints, others | Asymmetric | Possible | Yes | This table highlights the clinical distinctions that guide diagnosis and treatment selection.